Status:
COMPLETED
Measurement of Pro-angiogenic Markers in Patients With Hepatic Metastases Undergoing SIRT
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborating Sponsors:
Sirtex Medical
Conditions:
Liver Cancer
Eligibility:
All Genders
18-85 years
Brief Summary
This study is being done to investigate the influence of giving radiation to the liver on tumors involving the liver. Investigator is specifically looking at this effect on the blood vessels within th...
Detailed Description
Subjects are invited to participate in this study that have undergone a procedure as their standard of care. This procedure is known as Selective Internal Radiation Therapy (SIRT), a procedure designe...
Eligibility Criteria
Inclusion
- Patients between the ages of 18-85 who have been referred for SIRT as standard of care treatment for hepatocellular carcinoma or colorectal metastases to the liver and qualify for treatment with SIRT
- Life expectancy of at least 3 months
Exclusion
- \- Patients are excluded from participation in this study if they are not undergoing the SIRT procedure
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00994370
Start Date
April 1 2009
End Date
January 1 2013
Last Update
March 20 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert Wood Johnson University Hospital
New Brunswick, New Jersey, United States, 08901